We are live on ! Find out more
JGUA

John G. Ullman & Associates Portfolio holdings

AUM $754M
1-Year Est. Return 60.05%
This Fund
S&P 500
This Quarter Est. Return
+9.15%
1 Year Est. Return
+60.05%
3 Year Est. Return
+108.28%
5 Year Est. Return
+118.76%
10 Year Est. Return
+308.24%
AUM
$630M
AUM Growth
+$19.1M
Cap. Flow
-$22.7M
Cap. Flow %
-3.61%
Top 10 Hldgs %
32.12%
Holding
186
New
13
Increased
53
Reduced
79
Closed
17

Top Buys

Rank Stock Value
1
AVGO icon
Broadcom
AVGO
+$4.6M
2
LOW icon
Lowe's Companies
LOW
+$4.54M
3
GNRC icon
Generac Holdings
GNRC
+$4.05M
4
ZBH icon
Zimmer Biomet
ZBH
+$3.64M
5
CHWY icon
Chewy
CHWY
+$2.07M

Top Sells

Rank Stock Value
1
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
+$9.11M
2
VMW
VMware, Inc
VMW
+$6.88M
3
ACM icon
Aecom
ACM
+$6.65M
4
PFE icon
Pfizer
PFE
+$5.11M
5
BKH icon
Black Hills Corp
BKH
+$4.28M

Sector Composition

Rank Sector Weight
1 Technology 30.19%
2 Healthcare 17.08%
3 Industrials 16.64%
4 Utilities 9.87%
5 Energy 6.31%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
DAN icon
76
Dana Inc
DAN
$3.09B
$2.36M 0.37%
161,250
+66,900
+71% +$887K
LLY icon
77
Eli Lilly
LLY
$1.05T
$2.33M 0.37%
3,998
– –
ORCL icon
78
Oracle
ORCL
$422B
$2.29M 0.36%
21,730
-58
-0.3% -$6.33K
VNT icon
79
Vontier
VNT
$4.98B
$2.28M 0.36%
65,897
-600
-0.9% -$19.5K
SNOW icon
80
Snowflake
SNOW
$112B
$2.14M 0.34%
10,732
+3,782
+54% +$639K
BAX icon
81
Baxter International
BAX
$14.1B
$2.1M 0.33%
54,207
-15,622
-22% -$553K
UTHR icon
82
United Therapeutics
UTHR
$22.7B
$2.01M 0.32%
9,130
-100
-1% -$23K
TMP icon
83
Tompkins Financial
TMP
$1.41B
$1.89M 0.3%
31,443
-7,984
-20% -$434K
PBW icon
84
Invesco WilderHill Clean Energy ETF
PBW
$426M
$1.88M 0.3%
63,150
-34,200
-35% -$944K
SO icon
85
Southern Company
SO
$107B
$1.8M 0.29%
25,700
– –
WBS icon
86
Webster Financial
WBS
$12.8B
$1.62M 0.26%
31,850
+400
+1% +$17.3K
ASTE icon
87
Astec Industries
ASTE
$1.03B
$1.53M 0.24%
41,150
-3,100
-7% -$114K
BCV
88
Bancroft Fund
BCV
$139M
$1.48M 0.24%
92,772
+74,558
+409% +$1.13M
BE icon
89
Bloom Energy
BE
$64.5B
$1.2M 0.19%
81,200
+29,350
+57% +$367K
ALB icon
90
Albemarle
ALB
$15.2B
$1.17M 0.19%
8,075
-7,150
-47% -$982K
CFFI icon
91
C&F Financial
CFFI
$284M
$1.14M 0.18%
16,660
-100
-0.6% -$5.83K
VWO icon
92
Vanguard FTSE Emerging Markets ETF
VWO
$124B
$1.08M 0.17%
26,319
+20,900
+386% +$829K
KMI icon
93
Kinder Morgan
KMI
$69.1B
$1.08M 0.17%
61,120
-1,200
-2% -$20.5K
VIAV icon
94
Viavi Solutions
VIAV
$9.66B
$1.03M 0.16%
102,350
+16,300
+19% +$137K
ACVA icon
95
ACV Auctions
ACVA
$1.35B
$1M 0.16%
66,284
+1,000
+2% +$14.7K
CVX icon
96
Chevron
CVX
$367B
$985K 0.16%
6,601
+63
+1% +$9.53K
RBB icon
97
RBB Bancorp
RBB
$454M
$924K 0.15%
48,550
-600
-1% -$8.96K
ELUT icon
98
Elutia
ELUT
$38.3M
$890K 0.14%
29,700
– –
NEE icon
99
NextEra Energy
NEE
$177B
$881K 0.14%
14,497
+9,950
+219% +$567K
IR icon
100
Ingersoll Rand
IR
$34.2B
$862K 0.14%
11,142
-164
-1% -$11.2K
2 3
4
5 6

Similar funds

HCM
HMI Capital Management San Francisco, California $754M AUM 23.78% 1-Year Est. Return
FSCM
Front Street Capital Management Missoula, Montana $754M AUM 73.72% 1-Year Est. Return
RMC
Resources Management Corp West Hartford, Connecticut $753M AUM 20.77% 1-Year Est. Return
BEC
Blue Edge Capital Richmond, Virginia $753M AUM 18.89% 1-Year Est. Return
GFM
GCQ Funds Management Sydney, Australia $753M AUM 2.76% 1-Year Est. Return
TPW
Talon Private Wealth The Villages, Florida $753M AUM
MWA
Meridian Wealth Advisors Austin, Texas $756M AUM 21.36% 1-Year Est. Return
TCMI
Technology Crossover Management IX Menlo Park, California $752M AUM 25.7% 1-Year Est. Return

John G. Ullman & Associates's Q4 2023 Portfolio in Review

As of Q4 2023, John G. Ullman & Associates held 186 positions worth $630M, up 3.1% from $611M the previous quarter. Its ten largest holdings account for 32% of the portfolio.

John G. Ullman & Associates withdrew a net $22.7M in Q4 2023, closing 17 positions and reducing 79 holdings. Its most notable exit was Horizon Therapeutics Public Limited Company Ordinary Shares, an estimated $9.11M position sold in full.

By sector, the portfolio is most concentrated in Technology at 30% of assets, up from 28% a quarter earlier, followed by Healthcare and Industrials.

Against the trend, John G. Ullman & Associates opened a new position in Lowe's Companies worth $4.98M.

  • John G. Ullman & Associates's largest Q4 2023 buy was Lowe's Companies: 22,375 shares worth $4.98M.
  • John G. Ullman & Associates added most to Broadcom in Q4 2023, an estimated $4.6M increase.
  • John G. Ullman & Associates's biggest Q4 2023 reduction was Aecom, cutting an estimated $6.65M.
  • John G. Ullman & Associates fully exited Horizon Therapeutics Public Limited Company Ordinary Shares in Q4 2023, selling an estimated $9.11M.
  • John G. Ullman & Associates's ten largest holdings make up 32% of its $630M portfolio in Q4 2023.
  • John G. Ullman & Associates opened 13 new positions and closed 17 in Q4 2023.
  • John G. Ullman & Associates's portfolio value rose 3.1% quarter-over-quarter to $630M.

Based on John G. Ullman & Associates's 13F filing for Q4 2023, filed 31 Jan 2024.